Advertisement
Screener

GRAIL, Inc. (GRAL) ROE

GRAIL, Inc. ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • GRAIL, Inc. roe for the quarter ending 2026-06-30 was -15.40%, a change of 3.74% year-over-year.
  • GRAIL, Inc. roe for the quarter ending 2026-03-31 was -15.81%, a change of 63.50% year-over-year.
  • GRAIL, Inc. roe for the quarter ending 2025-12-31 was -15.84%, a change of 65.13% year-over-year.
  • GRAIL, Inc. roe for the quarter ending 2025-09-30 was -18.14%, a change of 63.69% year-over-year.
  • GRAIL, Inc. roe for fiscal 2025 was -15.84%, a change of 65.13% from fiscal 2024.
  • GRAIL, Inc. roe for fiscal 2024 was -80.97%.
Available history
2024-06-30 to 2026-06-30
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2026-06-30-15.40%-$391.59M-$110.25M$2.54B
2026-03-31-15.81%-$395.33M-$93.19M$2.5B
2025-12-31-15.84%-$408.35M-$99.18M$2.58B
2025-09-30-18.14%-$406.24M-$88.98M$2.24B
2025-06-30-19.14%-$442.95M-$113.98M$2.31B
2025-03-31-79.31%-$1.91B-$106.21M$2.41B
2024-12-31-80.97%-$2.03B-$97.07M$2.5B
2024-09-30-81.83%-$2.12B-$125.69M$2.59B
2024-06-30-106.98%-$2.88B-$1.59B$2.7B

Annual ROE

DateROENet income 12 monthShareholder equity
2025-12-31-15.84%-$408.35M$2.58B
2024-12-31-80.97%-$2.03B$2.5B

Similar stocks

Stock NameCountryMarket CapPE Ratio
RadNet, Inc. (RDNT)United States$5.611B-229.65
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70